On October 11, 2018 Johnson & Johnson Janssen pharmaceutical companies reported that it will present updates of their entire oncology portfolio at the 2018 annual congress of the European Society of Medical Oncology (ESMO) (Free ESMO Whitepaper), which will be held from 19 to 23 October in Munich, Germany (Press release, Johnson & Johnson, OCT 11, 2018, View Source [SID1234529866]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The statement in the original language is the official and authorized version thereof. The translation is only a means of help and should be compared with the text in the original language, which is the only version of the text that will have legal validity